Digital health—Spain—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Digital health—Spain—Q&A guide
  • 1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?
  • 2. How would you describe the investment climate for digital health technologies in your jurisdiction, including any noteworthy challenges?
  • 3. What are the most notable recent deals in the digital health sector in your jurisdiction?
  • 4. What due diligence issues should investors address before acquiring a stake in digital health ventures?
  • 5. What financing structures are commonly used by digital health ventures in your jurisdiction? Are there any notable government financing or other support initiatives to promote development of the digital health space?
  • 6. What principal legislation governs the digital health sector in your jurisdiction?
  • 7. Which notable regulatory and enforcement bodies have jurisdiction over the digital health sector?
  • 8. What licensing and authorisation requirements and procedures apply to the provision of digital health products and services in your jurisdiction?
  • 9. Is there any notable ‘soft’ law or guidance governing digital health?
  • More...

Digital health—Spain—Q&A guide

This Practice Note contains a jurisdiction-specific Q&A guide to digital health in Spain published as part of the Lexology Getting the Deal Through series by Law Business Research (published: June 2021).

Authors: Baker McKenzie—Ester Navas; Cecilia Pastor ; Raul Rubio

1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?

The Spanish digital health market is driven by multiple players. In recent years, innovation has been led by start-ups located mainly in the hubs of Barcelona and Madrid, which have leveraged the support of private investors to develop digital health solutions targeted at specific medical conditions.

However, the potential of this market has been recognised by more actors, in the light of the covid-19 pandemic. This is especially visible in the insurance sector, where many companies have developed their own apps and digital offers and included them as part of their insurance plans (Sanitas and BluaU, Allianz, DKV). Services implemented by insurance companies set their focus in telemedicine.

Pharmaceutical companies are also playing their role in the market, with the development of digital health apps (eg, MySugr, an app developed by Roche to assist diabetic patients) or the organisation of events aimed at discovering and promoting innovative ideas (Lilly with Emprende inHealth, Pfizer with Desafío e-Dea Salud).

From the public side, the degree of participation and

Popular documents